Hsbc Holdings PLC bought a new position in Maximus, Inc. (NYSE:MMS - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 17,845 shares of the health services provider's stock, valued at approximately $956,000.
A number of other institutional investors and hedge funds also recently modified their holdings of the stock. BlackRock Inc. acquired a new stake in Maximus during the 2nd quarter worth about $400,186,000. Reinhart Partners LLC. boosted its holdings in shares of Maximus by 131.8% in the second quarter. Reinhart Partners LLC. now owns 1,982,415 shares of the health services provider's stock worth $106,575,000 after buying an additional 1,127,346 shares during the period. Norges Bank acquired a new position in shares of Maximus in the fourth quarter worth about $60,393,000. River Road Asset Management LLC increased its position in shares of Maximus by 236.1% in the fourth quarter. River Road Asset Management LLC now owns 823,262 shares of the health services provider's stock worth $71,064,000 after acquiring an additional 578,326 shares in the last quarter. Finally, Bank of New York Mellon Corp purchased a new position in shares of Maximus in the second quarter worth approximately $26,239,000. 97.21% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several brokerages recently commented on MMS. Wall Street Zen downgraded shares of Maximus from a "buy" rating to a "hold" rating in a research report on Saturday, August 8th. Zacks Research downgraded shares of Maximus from a "hold" rating to a "strong sell" rating in a research note on Tuesday, August 11th. Finally, Weiss Ratings restated a "hold (c-)" rating on shares of Maximus in a report on Monday, August 17th. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, Maximus presently has an average rating of "Reduce".
View Our Latest Analysis on Maximus
Maximus Stock Down 0.2%
Shares of Maximus stock opened at $57.63 on Wednesday. Maximus, Inc. has a 12-month low of $52.73 and a 12-month high of $100.00. The company has a quick ratio of 2.42, a current ratio of 2.42 and a debt-to-equity ratio of 0.90. The stock has a 50 day moving average price of $57.77 and a two-hundred day moving average price of $63.27. The stock has a market capitalization of $3.02 billion, a P/E ratio of 8.51 and a beta of 0.59.
Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The health services provider reported $2.22 EPS for the quarter, beating analysts' consensus estimates of $2.21 by $0.01. The company had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.33 billion. Maximus had a net margin of 7.07% and a return on equity of 24.91%. The company's quarterly revenue was down 5.1% compared to the same quarter last year. During the same quarter last year, the firm posted $2.16 earnings per share. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. Equities analysts expect that Maximus, Inc. will post 8.03 earnings per share for the current year.
Maximus Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Monday, August 31st. Investors of record on Friday, August 14th were paid a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 2.3%. The ex-dividend date was Friday, August 14th. Maximus's dividend payout ratio is presently 19.50%.
Maximus Company Profile
(
Free Report)
Maximus, Inc NYSE: MMS is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children's Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.